CARLY MAHER: Open Payments
NPI 1841833928 · NAPLES, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,429 in 56 payments from 15 companies in 2025. Trend: 2023 $800 · 2024 $1,730 · 2025 $1,429
Food & beverage: $1,334Education: $95
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 20 | $358 |
| Arcutis Biotherapeutics, Inc. | 4 | $190 |
| Kerecis Limited | 2 | $172 |
| Incyte Corporation | 8 | $161 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 3 | $136 |
| Janssen Biotech, Inc. | 6 | $131 |
| Lilly USA, LLC | 2 | $54 |
| Novartis Pharmaceuticals Corporation | 2 | $51 |
| GENZYME CORPORATION | 1 | $43 |
| PFIZER INC. | 2 | $39 |
Products named: SKYRIZI, Zoryve, Kerecis SurgiClose, OPZELURA, TREMFYA, RINVOQ, TALTZ, DUPIXENT.
Industry payments across FL — which companies pay providers there.
